Supplementary Table 3 from Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity

MLA

W.P. Kloosterman, et al. Supplementary Table 3 from Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1541-7786.22516890.

APA

W.P. Kloosterman, Hugo J.G. Snippert, Emile E. Voest, Marco J. Koudijs, Robert M. van Es, Harmjan R. Vos, Ingrid Verlaan-Klink, Nizar Hami, Markus J. van Roosmalen, Jasmin B. Post, & Christina Stangl. (2023). Supplementary Table 3 from Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity. https://doi.org/10.1158/1541-7786.22516890

Chicago

W.P. Kloosterman, Hugo J.G. Snippert, Emile E. Voest, Marco J. Koudijs, Robert M. van Es, Harmjan R. Vos, Ingrid Verlaan-Klink, et al. 2023. “Supplementary Table 3 from Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity,” April. doi:10.1158/1541-7786.22516890.